About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,503 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,503 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4561-4580 of 7,503 trials

CompletedAdjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and RadiationThe purpose of this study is to evaluate time to progression (TTP) by PSA in patients with high risk prostate cancer after definitive therapy.NCT00186420·Stanford, California TerminatedMRI Guided Prostate Cancer Focal Laser AblationThe study is a prospective, single-arm, non-randomized, unblinded trial to determine the safety and efficacy of MRI guided focal laser ablation of localized low and intermediate…NCT03634579·Atlanta, Georgia UnknownRPCRC Validation StudyProstate multiparametric MRI (mpMRI) can detect ISUP ≥2 prostate cancer with high sensitivity.NCT04484103·Lyon

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

Active not recruitingLongitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate CancerThe prophylactic irradiation of pelvic lymph-nodes by means of Whole-Pelvis Radiotherapy (WPRT) in the treatment of prostate cancer (PCa) is aimed at the timely eradication of…NCT02803086·Milan

UnknownReIMAGINE Prostate Cancer RiskReIMAGINE Prostate Cancer Risk is a multi-centre, prospective, observational, longitudinal cohort study of men referred to secondary care with a suspicion of prostate cancer.NCT04060589·London and 2 others

Not yet recruitingPSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windowsa Phase II, single-arm, open-label, multi-center study to evaluate safety, tolerability, pharmacokinetics, and the effectiveness of near-infrared fluorescence imaging during…NCT07387510·Qingdao, Shandong

TerminatedAssess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCThis study will treat patients with Metastatic Castration Resistant Prostate Cancer who have progressed following prior therapy.NCT04634344·New York, New York and 5 others

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

CompletedCancer DNA Detection in Blood and UrineThis study is being conducted to collect and analyze biospecimens (blood and urine) and clinical data from patients with prostate cancer as well as healthy volunteers to better…NCT02657863·Baltimore, Maryland

UnknownStudy of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate CancerThe purpose of this study is to determine the clinical efficacy and toxicity of High-dose rate (HDR) brachytherapy as monotherapy for the treatment of low risk and intermediate…NCT02077335·Gatineau, Quebec

Enrolling by invitationAdvancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer SurvivorsThe purpose of this randomized clinical trial is to learn if 'complex' cancer patients who receive care guided by a health system intervention, Primary Care Connect (PC2) have…NCT06834204·New Brunswick, New Jersey

CompletedGemcitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00276549·Cleveland, Ohio

UnknownCyberKnife Radiosurgery for Localized Prostatic CarcinomaVirtual high dose rate (HDR) CyberKnife (CK) prostate treatment has comparable morbidity and efficacy compared with actual prostate HDR treatment, but does it without the…NCT01045148·San Diego, California

CompletedCalcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate CancerRATIONALE: Calcitriol, a form of vitamin D, may be able to prevent or slow the growth of prostate cancer cells.NCT00004043·Portland, Oregon

CompletedPositive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic SurgeryIn urologic robotic surgery with steep Trendelenburg position, maintenance of cardiac preload and cardiac output is important for clinical prognosis.NCT02977143·Seoul

CompletedReiki/Energy Healing in Prostate CancerThe purpose of this study is to determine whether Reiki energy healing affects anxiety and disease progression in patients with localized prostate cancer who are candidates for…NCT00065208·Cleveland, Ohio

CompletedEuropean Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-upThis is an open observational extended follow-up study of patients originally randomized into TOOKAD® Soluble VTP therapy or active surveillance (control group).NCT04017325·Tampere and 35 others

CompletedPhotoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility StudyThe purpose of our study is to image human prostate tissue using a transrectal photoacoustic imaging probe.NCT01551576·Stanford, California

Active not recruitingA Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate CancerThe primary objective of the study is to determine the therapeutic dose of RS-113 in patients with metastatic castration-resistant prostate cancer based on efficacy, safety, and…NCT07553988·Arkhangelsk and 15 others

Recruiting68Ga-PSMA PET/MRI in Conjunction With mpMRI for Evaluating Prospective Prostate Cancer RiskThe goal of this observational study is to learn if Ga-68 PSMA PET/MRI can better diagnose prostate cancer than mpMRI in males between 40 to 85 years old who is naive to prostate…NCT06494696·Taoyuan City

PreviousPage 229 of 376Next